Published in Neurodegener Dis on January 01, 2004
Retrieval of the Alzheimer's amyloid precursor protein from the endosome to the TGN is S655 phosphorylation state-dependent and retromer-mediated. Mol Neurodegener (2010) 1.25
Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci (2014) 0.98
Lithium and neuroprotection: translational evidence and implications for the treatment of neuropsychiatric disorders. Neuropsychiatr Dis Treat (2013) 0.95
Amyloid-β-induced amyloid-β secretion: a possible feed-forward mechanism in Alzheimer's Disease. J Alzheimers Dis (2011) 0.81
Comparison of pharmacological modulation of APP metabolism in primary chicken telencephalic neurons and in a human neuroglioma cell line. J Mol Neurosci (2010) 0.78
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21
Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J Biol Chem (1999) 6.44
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine. J Exp Med (2001) 5.06
The skeletal muscle chloride channel in dominant and recessive human myotonia. Science (1992) 4.28
Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (1990) 4.26
Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol (1993) 4.25
Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis (2000) 4.19
Algorithm for neuropathic pain treatment: an evidence based proposal. Pain (2005) 3.92
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A (2001) 3.80
Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest (1976) 3.65
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol (2000) 3.09
Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (1990) 3.09
A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science (2000) 3.06
Growth and transplantation of a custom vascularised bone graft in a man. Lancet (2004) 3.01
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. Neurology (1999) 2.74
The D-alanine residues of Staphylococcus aureus teichoic acids alter the susceptibility to vancomycin and the activity of autolytic enzymes. Antimicrob Agents Chemother (2000) 2.71
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA (1998) 2.64
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50
Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol (1998) 2.35
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol (1991) 2.25
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease. Neurology (2012) 2.23
Thymus medulla consisting of epithelial islets each derived from a single progenitor. Nature (2001) 2.18
Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study. BMJ (1998) 2.15
Clozapine rechallenge after an episode of 'neuroleptic malignant syndrome'. Br J Psychiatry (1992) 2.12
Neural network assessment of perioperative cardiac risk in vascular surgery patients. Med Decis Making (1998) 2.03
CNTF and endogenous psychoses? Nat Genet (1996) 2.02
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J (1997) 2.02
A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem (1997) 1.99
Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion (2001) 1.92
Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet (1996) 1.91
Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun (1999) 1.90
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry (1998) 1.86
Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology (2002) 1.84
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology (2012) 1.78
Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options. Eur J Neurol (2009) 1.76
Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. Int J Oral Maxillofac Surg (2004) 1.76
Proposal for a histopathological consensus classification of the periprosthetic interface membrane. J Clin Pathol (2006) 1.75
Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett (1997) 1.71
"The scarlet E": the presentation of epilepsy in the English language print media. Neurology (2000) 1.70
BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology (Oxford) (2005) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology (1998) 1.65
Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry (2004) 1.63
A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease. Ann Neurol (2000) 1.61
Integration of telomere sequences with the draft human genome sequence. Nature (2001) 1.59
Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry (2003) 1.58
Reduced levels of amyloid beta-peptide antibody in Alzheimer disease. Neurology (2001) 1.58
Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles. J Clin Endocrinol Metab (1998) 1.54
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study. Mol Psychiatry (2008) 1.54
Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment. Mol Psychiatry (2004) 1.53
Short course chemotherapy for tuberculous lymphadenitis in children. BMJ (1990) 1.51
Moderate alcohol consumption in social drinkers raises plasma homocysteine levels: a contradiction to the 'French Paradox'? Alcohol Alcohol (2001) 1.50
Prospective evaluation of malignant cell seeding after percutaneous endoscopic gastrostomy in patients with oropharyngeal/esophageal cancers. Endoscopy (2013) 1.49
Cell death and apoptosis regulating proteins in Parkinson's disease--a cautionary note. Acta Neuropathol (1999) 1.48
Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene (1999) 1.46
Efficacy of flupirtine on cognitive function in patients with CJD: A double-blind study. Neurology (2004) 1.45
The sleep-improving effects of doxepin are paralleled by a normalized plasma cortisol secretion in primary insomnia. A placebo-controlled, double-blind, randomized, cross-over study followed by an open treatment over 3 weeks. Psychopharmacology (Berl) (2003) 1.45
Prognostic value of baseline high-sensitivity C-reactive protein in patients undergoing replacement arthroplasty. JNMA J Nepal Med Assoc (2010) 1.45
A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. Proc Natl Acad Sci U S A (1998) 1.45
The component glycerides of an ox depot fat. Biochem J (1938) 1.44
Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. Mayo Clin Proc (1994) 1.44
Changes in heart rate during obstructive sleep apnoea. Eur Respir J (1992) 1.43
Lowered DNA methyltransferase (DNMT-3b) mRNA expression is associated with genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2006) 1.43
Persistent strains of coagulase-negative staphylococci in a neonatal intensive care unit: virulence factors and invasiveness. Clin Microbiol Infect (2007) 1.43
Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect Immun (1999) 1.43
Dietary habits of gallstone patients in Northern India. J Clin Gastroenterol (1996) 1.42
Does clozapine cause neuroleptic malignant syndrome? J Clin Psychiatry (1993) 1.41
Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem (2002) 1.40
[Recommendations for diagnosis, therapy and long-term management of patients with sleep apnea]. Med Klin (Munich) (1991) 1.40
H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect Immun (1996) 1.39
Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect Immun (2000) 1.39
[A short summary of the history of cognitive behavioural therapy]. Fortschr Neurol Psychiatr (2010) 1.39
Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Mol Psychiatry (2006) 1.38
Avoidance of implicit hazards: the realignment of maxillary and mandibular arches in comminuted and facial fractures. J Craniofac Surg (1998) 1.38
Improved electrophoretic separation and immunoblotting of beta-amyloid (A beta) peptides 1-40, 1-42, and 1-43. Electrophoresis (1997) 1.37
1,161 patients with adrenal incidentalomas: indications for surgery. Langenbecks Arch Surg (2007) 1.34
Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J Neural Transm (Vienna) (2004) 1.33
Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol (1999) 1.33
BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation. J Neural Transm (Vienna) (2007) 1.31
Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology (1994) 1.31
Human subtelomere structure and variation. Chromosome Res (2005) 1.31
Efficiency of specialist rehabilitation in reducing dependency and costs of continuing care for adults with complex acquired brain injuries. J Neurol Neurosurg Psychiatry (2006) 1.31
Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry (2004) 1.31
Molecular biology of pyridine nucleotide biosynthesis in Escherichia coli. Cloning and characterization of quinolinate synthesis genes nadA and nadB. Eur J Biochem (1988) 1.28
Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res (1995) 1.27
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies. Neurosci Biobehav Rev (1997) 1.27